ALS TDI Advances Two Drugs Toward The Clinic
The non-profit research organization, focused on the development of drugs for the treatment of ALS, is making clinical progress on two drugs, one of which is Novartis’ Gilenya.
The non-profit research organization, focused on the development of drugs for the treatment of ALS, is making clinical progress on two drugs, one of which is Novartis’ Gilenya.